These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31185734)

  • 1. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.
    Chui PW; Wang Y; Ranasinghe I; Mitiku TY; Seto AH; Rosman L; Lampert R; Minges KE; Enriquez AD; Curtis JP
    Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005374. PubMed ID: 31185734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.
    Curtis JP; Luebbert JJ; Wang Y; Rathore SS; Chen J; Heidenreich PA; Hammill SC; Lampert RI; Krumholz HM
    JAMA; 2009 Apr; 301(16):1661-70. PubMed ID: 19383957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study.
    Ranasinghe I; Parzynski CS; Freeman JV; Dreyer RP; Ross JS; Akar JG; Krumholz HM; Curtis JP
    Ann Intern Med; 2016 Jul; 165(1):20-29. PubMed ID: 27135392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.
    Koneru JN; Jones PW; Hammill EF; Wold N; Ellenbogen KA
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-evidence-based ICD implantations in the United States.
    Al-Khatib SM; Hellkamp A; Curtis J; Mark D; Peterson E; Sanders GD; Heidenreich PA; Hernandez AF; Curtis LH; Hammill S
    JAMA; 2011 Jan; 305(1):43-9. PubMed ID: 21205965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry.
    Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G
    Circulation; 2019 Nov; 140(19):1530-1539. PubMed ID: 31476893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry.
    Baskar S; Bao H; Minges KE; Spar DS; Czosek RJ
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006542. PubMed ID: 30354291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.
    Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E;
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of America.
    Li JZ; Bhonsale A; Estes NAM; Jain SK; Kancharla K; Mezu-Chukwu U; Saba S; Shalaby AA; Voigt AH; Wang NC
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007134. PubMed ID: 30841723
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician procedure volume and complications of cardioverter-defibrillator implantation.
    Freeman JV; Wang Y; Curtis JP; Heidenreich PA; Hlatky MA
    Circulation; 2012 Jan; 125(1):57-64. PubMed ID: 22095828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
    Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
    Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
    [No Abstract]   [Full Text] [Related]  

  • 17. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?
    Hess PL; Mi X; Curtis LH; Wilkoff BL; Hegland DD; Al-Khatib SM
    Heart Rhythm; 2013 Aug; 10(8):1127-33. PubMed ID: 23773989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after event-free cardioverter defibrillator implantation: comparison between patients discharged within 24 h and routinely hospitalized patients in the German DEVICE registry.
    Spitzer SG; Andresen D; Kuck KH; Seidl K; Eckardt L; Ulbrich M; Brachmann J; Gonska BD; Hoffmann E; Bauer A; Hochadel M; Senges J
    Europace; 2017 Jun; 19(6):968-975. PubMed ID: 27353325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.